Literature DB >> 19445844

Mesenchymal progenitor cells in red and yellow bone marrow.

O Gurevitch1, S Slavin, I Resnick, S Khitrin, A Feldman.   

Abstract

Marrow cavities in all bones of newborn mammals contain haematopoietic tissue and stromal microenvironment that support haematopoiesis (haematopoietic microenvironment), known as red bone marrow (BM). From the early postnatal period onwards, the haematopoietic microenvironment, mainly in tubular bones of the extremities, is replaced by mesenchymal cells that accumulate lipid drops, known as yellow BM, whereas haematopoietic tissue gradually disappears. We analysed the ability of mesenchymal cell progenitors in red and yellow BM to produce bone and haematopoietic microenvironment in vivo after transplantation into normal or haematopoietically deficient (irradiated and old) recipients. We found that (1) normal substitution of red with yellow BM results from a gradual loss of mesenchymal stem cells (MSCs) capable of developing bone and haematopoietic microenvironment; (2) the mesenchymal cell population in tubular bones still containing active haematopoietic tissue gradually becomes depleted of MSCs, starting from a young age; (3) haematopoietic microenvironment is incapable of self-maintenance and its renewal depends on the presence of precursor cells; (4) the mesenchymal cell population remaining in areas with yellow BM contains cells able to develop functionally active haematopoietic microenvironment in conditions of haematopoietic insufficiency. Our data also indicate the possible existence of bi-potential stromal precursor cells producing either bone in normal, or bone together with active haematopoietic microenvironment in irradiated or old recipients. This study opens a spectrum of opportunities for the extension of haematopoietic territories by substituting the fat contents of BM cavities with haematopoietic tissue, thereby improving haematopoiesis compromised by cytotoxic treatments, irradiation, ageing, etc.

Entities:  

Mesh:

Year:  2009        PMID: 19445844

Source DB:  PubMed          Journal:  Folia Biol (Praha)        ISSN: 0015-5500            Impact factor:   0.906


  6 in total

1.  1H-MRS of femoral red and yellow bone marrow fat composition and water content in healthy young men and women at 3 T.

Authors:  Jesper Lundbom; Alessandra Bierwagen; Kalman Bodis; Maria Apostolopoulou; Julia Szendroedi; Karsten Müssig; Jong-Hee Hwang; Michael Roden
Journal:  MAGMA       Date:  2019-05-02       Impact factor: 2.310

2.  Stem Cell Transplantation for Hematological Malignancies: Prospects for Personalized Medicine and Co-therapy with Mesenchymal Stem Cells.

Authors:  Shyam A Patel; Pranela Rameshwar
Journal:  Curr Pharmacogenomics Person Med       Date:  2011-09-01

3.  Hematoma-inspired alginate/platelet releasate/CaPO4 composite: initiation of the inflammatory-mediated response associated with fracture repair in vitro and ex vivo injection delivery.

Authors:  Jonathan D McCanless; Lisa K Jennings; Joel D Bumgardner; Judith A Cole; Warren O Haggard
Journal:  J Mater Sci Mater Med       Date:  2012-05-16       Impact factor: 3.896

4.  Bilateral osteoporotic bone marrow defects of the mandible: a case report.

Authors:  Diego Mauricio Bravo-Calderón; Denise Tostes Oliveira; Wagner Humberto Martins Dos Santos
Journal:  Head Face Med       Date:  2012-08-08       Impact factor: 2.151

5.  A preliminary study of osteochondral regeneration using a scaffold-free three-dimensional construct of porcine adipose tissue-derived mesenchymal stem cells.

Authors:  Daiki Murata; Satoshi Tokunaga; Tadashi Tamura; Hiroaki Kawaguchi; Noriaki Miyoshi; Makoto Fujiki; Koichi Nakayama; Kazuhiro Misumi
Journal:  J Orthop Surg Res       Date:  2015-03-18       Impact factor: 2.359

6.  Mesenchymal Stromal Cell-Derived Exosomes Affect mRNA Expression and Function of B-Lymphocytes.

Authors:  Drirh Khare; Reuven Or; Igor Resnick; Claudine Barkatz; Osnat Almogi-Hazan; Batia Avni
Journal:  Front Immunol       Date:  2018-12-21       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.